AOD-9604 research guide

AOD-9604 in United States — Sourcing Guide

Research-grade AOD-9604 sourcing guide for United States. COA verification, vendor selection, and handling protocols.

Browse Regions Order AOD-9604 →

AOD-9604 in United States: What Researchers Need to Know

Research peptides like AOD-9604 exist in a consistent grey zone across most countries: neither licensed pharmaceuticals nor controlled substances, and generally permissible to import for research use. What varies by country is import procedures, customs handling, and vendor shipping experience with the destination country — the quality evaluation framework itself does not change. United States researchers entering this space benefit most from engaging with established community resources as the safest starting point. This guide covers the country-specific context for AOD-9604 alongside the analytical verification criteria that are consistent globally.

The Science Behind AOD-9604

The GH axis research literature accessible to United States researchers spans from foundational biochemistry (pituitary GH secretion mechanisms, GHSR receptor pharmacology) to applied sports medicine and aging research. The depth of available mechanistic literature for GHS compounds like AOD-9604 is greater than for many newer research peptides, reflecting decades of pharmaceutical interest in this pathway. United States researchers entering this space have access to well-characterized assay systems, established animal models, and a substantial foundation of published dose-response data. This mechanistic foundation makes GHS research a relatively accessible entry point for researchers new to the peptide field.

Order AOD-9604 in United States
COA-verified · Ships to United States · International tracking
Order Now →

Browse by Region

Top Cities in United States

United States AOD-9604 Sourcing Guide

Sourcing AOD-9604 in United States follows the same framework as internationally, with one additional dimension: vendor experience shipping to United States. The COA verification step that United States researchers often skip is checking that the batch number on the COA corresponds to the lot number on the received vial — a COA is only meaningful when it is traceable to your particular vial. Online payment security and vendor credibility correlate in the research peptide space — vendors who support mainstream payment methods are taking on more obligation than suppliers who only accept wire transfer or digital currency. For United States researchers making their first AOD-9604 purchase: the combination of community forum research, direct COA review, and a conservative first order is the most reliable path to a successful first sourcing experience.

Handling AOD-9604 Safely

Handle AOD-9604 with standard research compound safety practices: sterile reconstitution technique, correct storage temperatures throughout, correct sharps handling and disposal. Storage requirements: lyophilised AOD-9604 at −20°C, reconstituted solution refrigerated at 2-8°C and used within 4 weeks — reconstitute only with bac water. From a pure handling safety perspective, AOD-9604 presents typical research-grade peptide handling requirements — sterile technique, appropriate storage, and quality-verified source material are the key considerations.

Order AOD-9604 — ships to United States
COA-verified · International shipping · All compounds research grade
Order Now →

Frequently Asked Questions

What is AOD-9604?

AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.

How does AOD-9604 differ from growth hormone?

AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.

What is the clinical trial history of AOD-9604?

AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.